Contrast media injectors are medical devices utilized to regulate the administration of contrast material before diagnostic imaging procedures like CT or MRI scans, enhancing the quality of the resulting images. These injectors are equipped with various features, including preset protocols and safety mechanisms, designed to prevent the extravasation of contrast media during the procedure.
By utilizing contrast media injectors, physicians can reduce the risk of potential complications such as the formation of air emboli resulting from improper injection of contrast material. Additionally, these injectors effectively minimize the volume of contrast material used, thereby significantly enhancing the contrast and overall image quality.
Market Insights & Analysis: Global Contrast Media Injectors Market (2023-28)
The Global Contrast Media Injectors Market is valued at USD1.3 billion in 2022 and is projected to grow at a CAGR of around 5.65% during the forecast period, i.e., 2023-28. The prevalence of chronic diseases is increasing, leading to a higher demand for medical imaging procedures that utilize Contrast Media injectors. These injectors enhance visibility in imaging tests, aiding in accurate diagnosis and treatment planning for conditions like cardiovascular disorders, cancer, and neurological conditions. Besides, the integration of advanced software and imaging technologies has improved imaging quality and reduced procedural errors, raising the demand further.
|Study Period||Historical Data: 2018-21|
|Base Year: 2022|
|Forecast Period: 2023-28|
|Regions Covered||North America: US, Canada, Mexico|
|Europe: Germany, The UK, France, Spain, Italy, Rest of Europe|
|Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific|
|South America: Brazil, Argentina, Rest of South America|
|Middle East & Africa: UAE, Saudi Arabia, South Africa, Rest of MEA|
|Key Companies Profiled||APOLLO RT CO. LTD., Bayer Healthcare Llc, Bracco Group, GE Healthcare [GE Company], Guerbet Group, Hilin Life Products, Hong Kong Medi Co Limited, Medtron Ag, Nemoto Kyorindo CO., LTD., SHENZHEN ANKE HIGH-TECH CO., LTD., SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD., SINO MEDICAL-DEVICE TECHNOLOGY CO., LTD., Ulrich Medical, Others|
|Unit Denominations||USD Million/Billion|
As the elderly population grows, the market for contrast-enhanced imaging techniques is expected to expand with frequent diagnostic imaging requirements and rising demand for minimally invasive procedures due to patient preferences and cost-effectiveness. Thus, contrast media injectors, a crucial medical device in MIS, are expected to gain traction as they offer benefits like shorter hospital stays and faster recovery times.
Lastly, Governments and healthcare organizations worldwide are investing in healthcare infrastructure and services, including advanced medical equipment like CMI, contributing to the market growth. This trend is driven by increasing healthcare expenditure and infrastructure development in emerging economies, as well as the expansion of private healthcare sectors.
Global Contrast Media Injectors Market Driver:
Rising Prevalence of Chronic Diseases Such as Cardiovascular Disorders, Cancer, And Neurological Conditions - Contrast Media injectors are commonly used in medical imaging procedures, including magnetic resonance imaging (MRI), computed tomography (CT), and angiography. These injectors help in enhancing the visibility of blood vessels and organs, facilitating accurate diagnosis and treatment planning. With the rising global burden of chronic diseases such as cardiovascular disorders, cancer, and neurological conditions, the demand for imaging procedures using Contrast Media injectors is projected to elevate further.
For instance, the WHO reports approximately 17.7 million people died of CVDs in 2015, likely rising to 23.6 million by 2030. Similarly, per the study, The Global Burden of Cardiovascular Diseases and Risk, published by JACC, Journal of the American College of Cardiology in December 2022, Cardiovascular diseases (CVDs) have collectively remained the leading causes of death globally, substantially contributing to the loss of health and additional costs on the health system.
Global Contrast Media Injectors Market Possible Restraint:
The pricing of contrast media injectors, consumables, and accessories may vary significantly, impacting the overall cost for hospitals and end users. Different types of injectors, such as single-head, dual-head, and syringeless injectors, come with other price points. For example, the GE-Nemoto Dual Shot NCOM (Class 4) CT Injector - Pedestal Mount is priced at approximately USD 40,600, while the GE-Nemoto Dual Shot NCOM (Class 4) CT Injector - Ceiling Mount for Long costs around USD 45,000.
In addition to the initial cost of the injectors, the recurring expenses associated with consumables and accessories add to the financial burden. Hygiene and safety considerations prevent the reuse of tubes and syringes, making their cost a significant factor. The cost of these consumables typically ranges from USD 350 to 500 each. These expenses further contribute to the overall cost of utilizing contrast media injector systems.
Global Contrast Media Injectors Market Key Trend:
Constantly Upgrading Health Care Equipment - The Contrast Media Injectors market has witnessed significant technological advancements in recent years. These advancements include the development of automated injectors that allow precise control over the injection rate, volume, and timing of the contrast media. Integration of advanced software and imaging technologies into injectors has also improved imaging quality and reduced the risk of errors during procedures. In addition, the introduction of syringeless and dual-head injectors has further enhanced the efficiency and convenience of contrast media administration, swiftly augmenting the market growth.
Global Contrast Media Injectors Market (2023-28): Segmentation Analysis
The Global Contrast Media Injectors Market study from MarkNtel Advisors analyzes the major trends in each sub-segment and includes predictions for the period 2023–28 at the global, regional, and national levels. The market has been segmented in our analysis based on Product & application:
Based On Product,
In the historical period, Contrast Media Injector Systems outpaced the consumables segment in terms of market share acquisition. With the wide application of such systems in CT and MRI scans in the detection and treatment of vascular disease, cancer, and orthopaedic injuries and disorders, the segment has witnessed a substantial surge in its adoption over the years.
On the other side, the growing demand for consumables in a bid to ensure safe and hygienic conditions during diagnostic procedures hints at massive consumables growth in the coming years. And, the recurring purchases of these consumables for radiology, interventional radiology, and interventional cardiology are expected to bode well for the segment's growth.
Based on Application,
Among other applications, Radiology is expected to lead the market through 2028 on account of the growing demand for contrast media injectors in radiology. In addition, the advancements in medical imaging technology, such as digital imaging and the integration of artificial intelligence, have further propelled the demand for radiology services. Moreover, the increasing cases of chronic diseases and the aging population have led to a surge in the need for accurate diagnostic imaging, thereby boosting the radiology segment's dominance in the global market.
Global Contrast Media Injectors Market Regional Projection
Geographically, the Contrast Media Injectors Market expands across:
North America emerged as a dominant player in the Global contrast media injectors market in 2022 and is expected to maintain its leading position throughout the forecast period. The dominance can be attributed to the well-established healthcare infrastructure in the region. In addition, factors such as the increasing preference for minimally invasive procedures and the rising prevalence of chronic diseases due to changing lifestyles contribute to the market's growth in North America.
On the contrary, the Asia Pacific market, with the rising prevalence of CVD and cancer, is anticipated to raise the adoption of high technologies and equipment in healthcare, including contrast media injectors in the coming years. The advancing health ecosystem here is driven by varied factors, including increased investments in research and development (R&D), a favorable demographic scenario in China, an aging population, and a high incidence of cancer cases in Japan.
Global Contrast Media Injectors Industry Recent Developments
Gain a Competitive Edge with Our Global Contrast Media Injectors Market Report
Frequently Asked Questions
A. The Contrast Media Injectors Market is projected to grow at a CAGR of around 5.65% during 2023-28.
A. Rising prevalence of chronic diseases such as cardiovascular disorders, cancer, and neurological conditions is likely to drive the market further during the projected time frame.
A. The prominent players anticipated to stiffen the competition globally are APOLLO RT CO. LTD., Bayer Healthcare Llc, Bracco Group, GE Healthcare (GE Company), Guerbet Group, Hilin Life Products, Hong Kong Medi Co Limitedm, Medtron Ag, Nemoto Kyorindo CO., LTD., SHENZHEN ANKE HIGH-TECH CO., LTD., SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD., SINO MEDICAL-DEVICE TECHNOLOGY CO., LTD., and Ulrich Medical.
A. Consumables is anticipated to emerge as an area of remunerative opportunities for the leading players in the Contrast Media Injectors Market during the forecast period.
A. Globally, Asia-Pacific would provide lucrative prospects for the Contrast Media Injectors Market in the years ahead.
A. Constantly upgrading health care equipment is the significant trend projected to shape the Contrast Media Injectors Market through 2028.
Global Contrast Media Injectors Market Research Report (2023-2028) - Table of Contents